These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
383 related articles for article (PubMed ID: 20799475)
21. Therapy of allergic bronchial asthma with omalizumab - an anti-IgE monoclonal antibody. D'Amato G Expert Opin Biol Ther; 2003 Apr; 3(2):371-6. PubMed ID: 12662149 [TBL] [Abstract][Full Text] [Related]
22. Effect of anti-immunoglobulin E on nasal inflammation in patients with seasonal allergic rhinoconjunctivitis. Bez C; Schubert R; Kopp M; Ersfeld Y; Rosewich M; Kuehr J; Kamin W; Berg AV; Wahu U; Zielen S Clin Exp Allergy; 2004 Jul; 34(7):1079-85. PubMed ID: 15248853 [TBL] [Abstract][Full Text] [Related]
32. [Specific immunotherapy and therapeutic strategies in allergic diseases. What's new?]. Tonnel AB Bull Acad Natl Med; 2005 Oct; 189(7):1475-87; discussion 1488-9. PubMed ID: 16669146 [TBL] [Abstract][Full Text] [Related]
33. Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR. Vignola AM; Humbert M; Bousquet J; Boulet LP; Hedgecock S; Blogg M; Fox H; Surrey K Allergy; 2004 Jul; 59(7):709-17. PubMed ID: 15180757 [TBL] [Abstract][Full Text] [Related]
35. Injection of anti-IgE antibodies will suppress IgE and allergic symptoms. Patalano F Allergy; 1999 Feb; 54(2):103-10. PubMed ID: 10221432 [No Abstract] [Full Text] [Related]
36. [Allergic march in children, from rhinitis to asthma: management, indication of immunotherapy]. Scheinmann P; Pham Thi N; Karila C; de Blic J Arch Pediatr; 2012 Mar; 19(3):330-4. PubMed ID: 22306361 [TBL] [Abstract][Full Text] [Related]
37. The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation. Holgate S; Casale T; Wenzel S; Bousquet J; Deniz Y; Reisner C J Allergy Clin Immunol; 2005 Mar; 115(3):459-65. PubMed ID: 15753888 [TBL] [Abstract][Full Text] [Related]